BOSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, announced today that it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback